UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in BBIO — BridgeBio Pharma, Inc.
CIK 861177
NEW YORK, NY
Position in BBIO
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$29,922,913
-$4,575,296 QoQ
Shares Held
402,948
-10.7% QoQ
Ownership
0.206%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 60%
Shared 0%
None 40%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,037,771 across 211 Biotechnology names. BBIO ranks #22 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in BBIO
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $29,922,913 | 402,948 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $34,498,209 | 451,016 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $26,658,876 | 513,263 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $30,414,131 | 704,357 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $20,912,979 | 604,946 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $16,727,091 | 609,588 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $16,810,343 | 660,265 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $17,886,192 | 706,127 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $19,847,391 | 641,895 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $26,652,997 | 660,218 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $18,343,838 | 695,633 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $12,117,155 | 704,486 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $11,680,375 | 704,486 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $792,211 | 103,965 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,071,907 | 107,838 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $768,964 | 84,688 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $664,407 | 65,459 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,083,548 | 64,961 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,313,519 | 70,696 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,217,393 | 69,183 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,429,564 | 39,441 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $11,761,735 | 165,402 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $6,543,299 | 174,395 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $5,770,371 | 176,951 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $4,899,434 | 168,946 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||